Poultry Pharmaceuticals Market to Reach US$ 7.8 Billion by 2024 - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024: Transparency Market Research

News provided by

Transparency Market Research

14 Sep, 2016, 13:03 GMT

ALBANY, New York, September 14, 2016 /PRNewswire/ --

The poultry pharmaceuticals market is dominated by Merck Animal Health and Zoetis Inc. and the two companies together accounted for over half the market in 2015. The rest of the market is, however, fragmented and is characterized by the presence of several large and small players. Transparency Market Research notes that the rivalry within the animal healthcare industry is quite high due to the existence of a large number of players and this trend is also reflected in the global poultry pharmaceutical market. "The high degree of competition ensures that poultry pharmaceutical companies maintain regular interaction and collaborations with drug retailers, governments, and poultry farmers," the author of the study states.

The revenue generated by the global poultry pharmaceuticals market was pegged at US$3.7 bn in 2015 and is projected to reach US$7.8 bn by 2024, registering a healthy CAGR of 8.5% during the forecast period.

Interpret a Competitive outlook Analysis Report with free PDF Brochure: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=11486

Product innovation has also proven to be a successful strategy adopted by players in the poultry pharmaceutical market, TMR finds. For instance, in September 2015, Merial Animal Health globally launched its innovation in poultry vaccination technology, known as Merial Avinew. This move has strengthened Merial's position in the market.

North America and Latin America Emerge as Most Promising Markets for Poultry Pharmaceuticals 

By type of product, vaccines held the leading share in the global poultry pharmaceuticals market in terms of revenue, accounting for just over 41% in 2016. Feed additive medications, on the other hand, will register an 8.8% CAGR during the forecast period, emerging as a highly lucrative product segment.

Based on type of animal, chicken is the key contributor to the overall market and is likely to remain so through 2024. The segment will also register a higher growth rate than any other category. Geographically, while North America dominates the global poultry pharmaceutical market, accounting for just short of 36% in 2016, Latin America is forecast to clock in the highest CAGR of 9.2% from 2016 to 2024.

View exclusive Global Strategic Business report: http://www.transparencymarketresearch.com/poultry-pharmaceuticals-market.html

Rising Poultry Franchises in Emerging Nations a Key Growth Driver 

The Food and Agriculture Organization (FAO) in the U.S states that the demand for food is expected to double due to the increase in global population, which is projected to be around 9.1 billion by 2050. In order to cater to this ever-rising demand for food, the number of poultry farming operations and franchises has increased significantly in recent years. China, Brazil, Mexico, India, Russia, and Argentina are among the leading countries with a high growth rate in terms of poultry animal ownership. This has benefited the poultry pharmaceutical market.

Apart from this, the poultry pharmaceuticals market is fueled by the growing emphasis on wellness and preventive care by veterinarians and poultry animal owners, the rising consumption of animal protein, the increasing incidence of poultry diseases, and the support from government and private organizations in the form of vaccination initiatives.

In contrast, the poultry pharmaceutical market is hampered by stringent regulations, lengthy product approval periods, and limited vaccination production. The growing concerns regarding the use of antibiotics and growth promoters in animal feed are also hindering the growth of the global market.

This review is based on the findings of a TMR report titled "Poultry Pharmaceuticals Market - (By Product - Drugs, Vaccines, Feed Additive, and Medication; By Animal Type - Chicken, Turkey, Duck, Goose, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024."

Browse Global Industry PR:  http://www.europlat.org/poultry-pharmaceuticals-market.htm

Global Poultry Pharmaceuticals Market, by Product Type 

  • Drugs
    • VETRIMOXIN
    • Other Drug Products
  • Vaccines
    • INNOVAX
    • NOBILIS
    • Poulvac
    • Other Vaccine Products
  • Feed Additive Medication
    • VIGOSINE
    • Amnovit
    • Other Feed Additive Medication

Global Poultry Pharmaceuticals Market, by Animal Type 

  • Chicken
  • Turkey
  • Duck
  • Goose
  • Others

Global Poultry Pharmaceuticals Market, by Geography 

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • South Africa
    • Rest of Middle East & Africa

Browse Other Latest Research Reports:  

About Us: 

Transparency Market Research (TMR) is a U.S. based provider of syndicated research, customized research, and consulting services. TMR's global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

US Office Contact 
Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Blog: http://www.tmrblog.com/